‘Smart bombs’ against cancer at Johns Hopkins
Three leading scientists from the Johns Hopkins University School of Medicine in Baltimore spoke to Kathimerini in Athens last week about the latest scientific achievements in the treatment of prostate cancer and cardiovascular disease. Dr Theodore L. DeWeese, an associate professor of oncology and chairman of the university’s Department of Radiation Oncology and Molecular Radiation Sciences, discussed the advanced methods of radiation therapy for prostate cancer being applied at Johns Hopkins, as well as research into targeting the repair mechanism of cells. Alan W. Heldman, an associate professor of cardiology, talked about the positive work with stem cells that can be used to deal with the effects of myocardial attacks. He also describes the advantages of the use of drug-eluting stents in opening up coronary arteries. Professor Charles W. Cummings, vice president for medical affairs at Johns Hopkins Medicine International, spoke about the institution’s history and goals.
